{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:04:21Z","timestamp":1767031461472,"version":"3.48.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303140"],"award-info":[{"award-number":["82303140"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82172147"],"award-info":[{"award-number":["82172147"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province,China","doi-asserted-by":"crossref","award":["2025JJ60600"],"award-info":[{"award-number":["2025JJ60600"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hunan Province,China","doi-asserted-by":"crossref","award":["2016JJ2157"],"award-info":[{"award-number":["2016JJ2157"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"crossref","award":["2021JJ30900"],"award-info":[{"award-number":["2021JJ30900"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04038-1","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T14:24:39Z","timestamp":1763648679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-WNT\/non-SHH medulloblastoma in siblings: case report and literature review"],"prefix":"10.1007","volume":"16","author":[{"given":"Meng","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxiang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haipeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"4038_CR1","doi-asserted-by":"publisher","unstructured":"Sheng H, Li H, Zeng H, Zhang B, Lu Y, Liu X, et al. Heterogeneity and tumoral origin of medulloblastoma in the single-cell era. Oncogene. 2024;43(12):839-50. https:\/\/doi.org\/10.1038\/s41388-024-02967-9","DOI":"10.1038\/s41388-024-02967-9"},{"key":"4038_CR2","doi-asserted-by":"crossref","unstructured":"Ramaswamy V, Taylor MD. Medulloblastoma: From Myth to Molecular. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017;35(21):2355-63.","DOI":"10.1200\/JCO.2017.72.7842"},{"issue":"1","key":"4038_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-019-0063-6","volume":"5","author":"PA Northcott","year":"2019","unstructured":"Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, et al. Medulloblastoma Nat Rev Dis Primers. 2019;5(1):11.","journal-title":"Medulloblastoma Nat Rev Dis Primers"},{"issue":"9","key":"4038_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41582-022-00679-w","volume":"18","author":"C Horbinski","year":"2022","unstructured":"Horbinski C, Berger T, Packer RJ, Wen PY. Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours. Nat Reviews Neurol. 2022;18(9):515\u201329.","journal-title":"Nat Reviews Neurol"},{"key":"4038_CR5","doi-asserted-by":"crossref","unstructured":"Foti A, Allia F, Briglia M, Malaguarnera R, Tamburrini G, Cecconi F, et al. Medulloblastoma: molecular targets and innovative theranostic approaches. Pharmaceutics. 2025;17(6).","DOI":"10.3390\/pharmaceutics17060736"},{"issue":"1","key":"4038_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-neuro-112723-061540","volume":"48","author":"KM Kiang","year":"2025","unstructured":"Kiang KM, Wong YKH, Sengupta S, Roussel MF, Lu QR. Developmental origins and oncogenesis in Medulloblastoma. Annu Rev Neurosci. 2025;48(1):85\u2013102.","journal-title":"Annu Rev Neurosci"},{"issue":"5","key":"4038_CR7","doi-asserted-by":"publisher","first-page":"111162","DOI":"10.1016\/j.celrep.2022.111162","volume":"40","author":"D Williamson","year":"2022","unstructured":"Williamson D, Schwalbe EC, Hicks D, Aldinger KA, Lindsey JC, Crosier S, et al. Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development. Cell Rep. 2022;40(5):111162.","journal-title":"Cell Rep"},{"key":"4038_CR8","doi-asserted-by":"publisher","first-page":"988798","DOI":"10.3389\/fonc.2022.988798","volume":"12","author":"Y Chen","year":"2022","unstructured":"Chen Y, Zhang H, Zhao Y, Ma J. Congenital Medulloblastoma in two brothers with SUFU-mutated Gorlin-Goltz syndrome: case reports and literature review. Front Oncol. 2022;12:988798.","journal-title":"Front Oncol"},{"issue":"4","key":"4038_CR9","doi-asserted-by":"publisher","first-page":"e28912","DOI":"10.1002\/pbc.28912","volume":"68","author":"M Massimino","year":"2021","unstructured":"Massimino M, Signoroni S, Boschetti L, Chiapparini L, Erbetta A, Biassoni V, et al. Medulloblastoma and Familial adenomatous polyposis: good prognosis and good quality of life in the long-term? Pediatr Blood Cancer. 2021;68(4):e28912.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"4038_CR10","first-page":"375","volume":"8","author":"S Farouk Sait","year":"2021","unstructured":"Farouk Sait S, Walsh MF, Karajannis MA. Genetic syndromes predisposing to pediatric brain tumors. Neurooncol Pract. 2021;8(4):375\u201390.","journal-title":"Neurooncol Pract"},{"issue":"7803","key":"4038_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41586-020-2164-5","volume":"580","author":"SM Waszak","year":"2020","unstructured":"Waszak SM, Robinson GW, Gudenas BL, Smith KS, Forget A, Kojic M, et al. Germline elongator mutations in Sonic Hedgehog Medulloblastoma. Nature. 2020;580(7803):396\u2013401.","journal-title":"Nature"},{"key":"4038_CR12","doi-asserted-by":"publisher","first-page":"107516","DOI":"10.1016\/j.pharmthera.2020.107516","volume":"210","author":"X Liu","year":"2020","unstructured":"Liu X, Ding C, Tan W, Zhang A, Medulloblastoma. Molecular understanding, treatment evolution, and new developments. Pharmacol Ther. 2020;210:107516.","journal-title":"Pharmacol Ther"},{"issue":"12","key":"4038_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s11910-023-01316-9","volume":"23","author":"K Jackson","year":"2023","unstructured":"Jackson K, Packer RJ. Recent advances in pediatric Medulloblastoma. Curr Neurol Neurosci Rep. 2023;23(12):841\u20138.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"10","key":"4038_CR14","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1200\/JCO.2008.17.9432","volume":"27","author":"S Pfister","year":"2009","unstructured":"Pfister S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, et al. Outcome prediction in pediatric Medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncology: Official J Am Soc Clin Oncol. 2009;27(10):1627\u201336.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"18","key":"4038_CR15","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1200\/JCO.2009.25.7121","volume":"28","author":"A Korshunov","year":"2010","unstructured":"Korshunov A, Remke M, Werft W, Benner A, Ryzhova M, Witt H, et al. Adult and pediatric Medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. J Clin Oncology: Official J Am Soc Clin Oncol. 2010;28(18):3054\u201360.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"2","key":"4038_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1023\/A:1010624702443","volume":"51","author":"J Guyotat","year":"2001","unstructured":"Guyotat J, Champier J, Pierre GS, Jouvet A, Bret P, Brisson C, et al. Differential expression of somatostatin receptors in Medulloblastoma. J Neurooncol. 2001;51(2):93\u2013103.","journal-title":"J Neurooncol"},{"issue":"11","key":"4038_CR17","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1158\/1541-7786.MCR-21-0117","volume":"19","author":"C Adolphe","year":"2021","unstructured":"Adolphe C, Millar A, Kojic M, Barkauskas DS, Sundstrom A, Swartling FJ, et al. SOX9 defines distinct populations of cells in SHH Medulloblastoma but is not required for Math1-Driven tumor formation. Mol Cancer Research: MCR. 2021;19(11):1831\u20139.","journal-title":"Mol Cancer Research: MCR"},{"issue":"7","key":"4038_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1080\/1354750X.2023.2276670","volume":"28","author":"Q Li","year":"2023","unstructured":"Li Q, Jia Y, Tang B, Yang H, Yang Q, Luo X, et al. Mitochondrial subtype MB-G3 contains potential novel biomarkers and therapeutic targets associated with prognosis of Medulloblastoma. Biomarkers. 2023;28(7):643\u201351.","journal-title":"Biomarkers"},{"issue":"1","key":"4038_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00006123-200207000-00035","volume":"51","author":"CS von Koch","year":"2002","unstructured":"von Koch CS, Gulati M, Aldape K, Berger MS. Familial medulloblastoma: case report of one family and review of the literature. Neurosurgery. 2002;51(1):227\u201333. discussion 33.","journal-title":"Neurosurgery"},{"issue":"5","key":"4038_CR20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/bjc.1991.435","volume":"64","author":"DG Evans","year":"1991","unstructured":"Evans DG, Farndon PA, Burnell LD, Gattamaneni HR, Birch JM. The incidence of Gorlin syndrome in 173 consecutive cases of Medulloblastoma. Br J Cancer. 1991;64(5):959\u201361.","journal-title":"Br J Cancer"},{"issue":"3","key":"4038_CR21","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/cncr.11537","volume":"98","author":"SF Amlashi","year":"2003","unstructured":"Amlashi SF, Riffaud L, Brassier G, Morandi X. Nevoid basal cell carcinoma syndrome: relation with desmoplastic Medulloblastoma in infancy. A population-based study and review of the literature. Cancer. 2003;98(3):618\u201324.","journal-title":"Cancer"},{"issue":"7","key":"4038_CR22","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1158\/1078-0432.CCR-08-2023","volume":"15","author":"ML Garre","year":"2009","unstructured":"Garre ML, Cama A, Bagnasco F, Morana G, Giangaspero F, Brisigotti M, et al. Medulloblastoma variants: age-dependent occurrence and relation to Gorlin syndrome\u2013a new clinical perspective. Clin Cancer Research: Official J Am Association Cancer Res. 2009;15(7):2463\u201371.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"6","key":"4038_CR23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1470-2045(18)30242-0","volume":"19","author":"SM Waszak","year":"2018","unstructured":"Waszak SM, Northcott PA, Buchhalter I, Robinson GW, Sutter C, Groebner S, et al. Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort. Lancet Oncol. 2018;19(6):785\u201398.","journal-title":"Lancet Oncol"},{"issue":"23","key":"4038_CR24","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1200\/JCO.2012.48.5052","volume":"31","author":"N Zhukova","year":"2013","unstructured":"Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih DJ, Martin DC, et al. Subgroup-specific prognostic implications of TP53 mutation in Medulloblastoma. J Clin Oncology: Official J Am Soc Clin Oncol. 2013;31(23):2927\u201335.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"9","key":"4038_CR25","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S1470-2045(16)30249-2","volume":"17","author":"A Villani","year":"2016","unstructured":"Villani A, Shore A, Wasserman JD, Stephens D, Kim RH, Druker H, et al. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study. Lancet Oncol. 2016;17(9):1295\u2013305.","journal-title":"Lancet Oncol"},{"issue":"8","key":"4038_CR26","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1200\/JCO.2009.23.5952","volume":"28","author":"U Tabori","year":"2010","unstructured":"Tabori U, Baskin B, Shago M, Alon N, Taylor MD, Ray PN, et al. Universal poor survival in children with Medulloblastoma harboring somatic TP53 mutations. J Clin Oncology: Official J Am Soc Clin Oncol. 2010;28(8):1345\u201350.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"7663","key":"4038_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature22973","volume":"547","author":"PA Northcott","year":"2017","unstructured":"Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, et al. The whole-genome landscape of Medulloblastoma subtypes. Nature. 2017;547(7663):311\u20137.","journal-title":"Nature"},{"issue":"1","key":"4038_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12964-022-00930-3","volume":"20","author":"MM Georgescu","year":"2022","unstructured":"Georgescu MM, Whipple SG, Notarianni CM. Novel neoplasms associated with syndromic pediatric medulloblastoma: integrated pathway delineation for personalized therapy. Cell Commun Signal. 2022;20(1):123.","journal-title":"Cell Commun Signal"},{"key":"4038_CR29","doi-asserted-by":"crossref","unstructured":"Silva FLT, Ruas JS, Euzebio MF, Hoffmann IL, Junqueira T, Tedeschi H, et al. 11p15 epimutations in pediatric embryonic tumors: insights from a methylome analysis. Cancers. 2023;15(17).","DOI":"10.3390\/cancers15174256"},{"issue":"1","key":"4038_CR30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ajmg.1320470119","volume":"47","author":"JM Olson","year":"1993","unstructured":"Olson JM, Breslow NE, Barce J. Cancer in twins of Wilms tumor patients. Am J Med Genet. 1993;47(1):91\u20134.","journal-title":"Am J Med Genet"},{"key":"4038_CR31","unstructured":"Albrecht S, Miedzybrodzki B, Palma L, Nguyen VH, Dudley RWR, Pietsch T, et al. Medulloblastoma and Cowden syndrome: further evidence of an association. Free Neuropathol. 2022;3."},{"issue":"2","key":"4038_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/pbc.24765","volume":"61","author":"F Bourdeaut","year":"2014","unstructured":"Bourdeaut F, Miquel C, Richer W, Grill J, Zerah M, Grison C, et al. Rubinstein-Taybi syndrome predisposing to non-WNT, non-SHH, group 3 Medulloblastoma. Pediatr Blood Cancer. 2014;61(2):383\u20136.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"4038_CR33","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.devcel.2018.02.012","volume":"44","author":"DJ Merk","year":"2018","unstructured":"Merk DJ, Ohli J, Merk ND, Thatikonda V, Morrissy S, Schoof M, et al. Opposing effects of CREBBP mutations govern the phenotype of Rubinstein-Taybi syndrome and adult SHH Medulloblastoma. Dev Cell. 2018;44(6):709\u201324. e6.","journal-title":"Dev Cell"},{"issue":"4","key":"4038_CR34","doi-asserted-by":"publisher","first-page":"a016600","DOI":"10.1101\/cshperspect.a016600","volume":"7","author":"R Prakash","year":"2015","unstructured":"Prakash R, Zhang Y, Feng W, Jasin M. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins. Cold Spring Harb Perspect Biol. 2015;7(4):a016600.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"4038_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1200\/JCO.19.00577","volume":"38","author":"M Begemann","year":"2020","unstructured":"Begemann M, Waszak SM, Robinson GW, Jager N, Sharma T, Knopp C, et al. Germline GPR161 mutations predispose to pediatric Medulloblastoma. J Clin Oncology: Official J Am Soc Clin Oncol. 2020;38(1):43\u201350.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"1\u20132","key":"4038_CR36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cell.2012.12.026","volume":"152","author":"S Mukhopadhyay","year":"2013","unstructured":"Mukhopadhyay S, Wen X, Ratti N, Loktev A, Rangell L, Scales SJ, et al. The ciliary G-protein-coupled receptor Gpr161 negatively regulates the Sonic Hedgehog pathway via cAMP signaling. Cell. 2013;152(1\u20132):210\u201323.","journal-title":"Cell"},{"key":"4038_CR37","doi-asserted-by":"publisher","first-page":"566822","DOI":"10.3389\/fonc.2020.566822","volume":"10","author":"R Carta","year":"2020","unstructured":"Carta R, Del Baldo G, Miele E, Po A, Besharat ZM, Nazio F, et al. Cancer predisposition syndromes and Medulloblastoma in the molecular era. Front Oncol. 2020;10:566822.","journal-title":"Front Oncol"},{"issue":"21","key":"4038_CR38","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1200\/JCO.2016.71.7199","volume":"35","author":"J Campian","year":"2017","unstructured":"Campian J, Gutmann DH. CNS tumors in neurofibromatosis. J Clin Oncology: Official J Am Soc Clin Oncol. 2017;35(21):2378\u201385.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"4038_CR39","doi-asserted-by":"crossref","unstructured":"Ranalli M, Boni A, Caroleo AM, Del Baldo G, Rinelli M, Agolini E, et al. Molecular characterization of medulloblastoma in a patient with neurofibromatosis type 1: case report and literature review. Diagnostics. 2021;11(4).","DOI":"10.3390\/diagnostics11040647"},{"issue":"11","key":"4038_CR40","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00381-010-1163-5","volume":"26","author":"I Pascual-Castroviejo","year":"2010","unstructured":"Pascual-Castroviejo I, Pascual-Pascual SI, Viano J, Carceller F, Gutierrez-Molina M, Morales C, et al. Posterior fossa tumors in children with neurofibromatosis type 1 (NF1). Childs Nerv Syst. 2010;26(11):1599\u2013603.","journal-title":"Childs Nerv Syst"},{"issue":"8","key":"4038_CR41","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","volume":"13","author":"AC Hirbe","year":"2014","unstructured":"Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol. 2014;13(8):834\u201343.","journal-title":"Lancet Neurol"},{"issue":"1","key":"4038_CR42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12967-022-03554-w","volume":"20","author":"EE Abd El-Fattah","year":"2022","unstructured":"Abd El-Fattah EE. IDO\/kynurenine pathway in cancer: possible therapeutic approaches. J Transl Med. 2022;20(1):347.","journal-title":"J Transl Med"},{"key":"4038_CR43","doi-asserted-by":"publisher","first-page":"173921","DOI":"10.1016\/j.ejphar.2021.173921","volume":"896","author":"M Ala","year":"2021","unstructured":"Ala M. The footprint of kynurenine pathway in every cancer: a new target for chemotherapy. Eur J Pharmacol. 2021;896:173921.","journal-title":"Eur J Pharmacol"},{"key":"4038_CR44","doi-asserted-by":"crossref","unstructured":"Gouasmi R, Ferraro-Peyret C, Nancey S, Coste I, Renno T, Chaveroux C, et al. The kynurenine pathway and cancer: why keep it simple when you can make it complicated. Cancers. 2022;14(11).","DOI":"10.3390\/cancers14112793"},{"key":"4038_CR45","doi-asserted-by":"crossref","unstructured":"Pham K, Hanaford AR, Poore BA, Maxwell MJ, Sweeney H, Parthasarathy A, et al. Comprehensive metabolic profiling of MYC-Amplified Medulloblastoma tumors reveals key dependencies on amino acid, Tricarboxylic acid and hexosamine pathways. Cancers. 2022;14(5).","DOI":"10.3390\/cancers14051311"},{"issue":"12","key":"4038_CR46","first-page":"2287","volume":"25","author":"AR Wolin","year":"2023","unstructured":"Wolin AR, Vincent MY, Hotz T, Purdy SC, Rosenbaum SR, Hughes CJ, et al. EYA2 tyrosine phosphatase Inhibition reduces MYC and prevents Medulloblastoma progression. Neurooncology. 2023;25(12):2287\u2013301.","journal-title":"Neurooncology"},{"issue":"1","key":"4038_CR47","first-page":"237","volume":"27","author":"M Adiamah","year":"2025","unstructured":"Adiamah M, Poole B, Lindsey JC, Kohe S, Morcavallo A, Burte F, et al. MYC-dependent upregulation of the de Novo Serine and Glycine synthesis pathway is a targetable metabolic vulnerability in group 3 Medulloblastoma. Neurooncology. 2025;27(1):237\u201353.","journal-title":"Neurooncology"},{"issue":"1","key":"4038_CR48","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s12864-017-3595-8","volume":"18","author":"C Bekpen","year":"2017","unstructured":"Bekpen C, Kunzel S, Xie C, Eaaswarkhanth M, Lin YL, Gokcumen O, et al. Segmental duplications and evolutionary acquisition of UV damage response in the SPATA31 gene family of primates and humans. BMC Genomics. 2017;18(1):222.","journal-title":"BMC Genomics"},{"issue":"9","key":"4038_CR49","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/s41436-020-0840-3","volume":"22","author":"A Topf","year":"2020","unstructured":"Topf A, Johnson K, Bates A, Phillips L, Chao KR, England EM, et al. Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness. Genet Med. 2020;22(9):1478\u201388.","journal-title":"Genet Med"},{"issue":"2","key":"4038_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ajhg.2009.12.013","volume":"86","author":"V Bolduc","year":"2010","unstructured":"Bolduc V, Marlow G, Boycott KM, Saleki K, Inoue H, Kroon J, et al. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. Am J Hum Genet. 2010;86(2):213\u201321.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"4038_CR51","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00232-005-0781-4","volume":"205","author":"K Kunzelmann","year":"2005","unstructured":"Kunzelmann K. Ion channels and cancer. J Membr Biol. 2005;205(3):159\u201373.","journal-title":"J Membr Biol"},{"issue":"4","key":"4038_CR52","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3892\/ijo.2017.4113","volume":"51","author":"Z Chang","year":"2017","unstructured":"Chang Z, Cai C, Han D, Gao Y, Li Q, Feng L, et al. Anoctamin5 regulates cell migration and invasion in thyroid cancer. Int J Oncol. 2017;51(4):1311\u20139.","journal-title":"Int J Oncol"},{"issue":"7","key":"4038_CR53","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1002\/cam4.2909","volume":"9","author":"CC Yu","year":"2020","unstructured":"Yu CC, Chen LC, Huang CY, Lin VC, Lu TL, Lee CH, et al. Genetic association analysis identifies a role for ANO5 in prostate cancer progression. Cancer Med. 2020;9(7):2372\u20138.","journal-title":"Cancer Med"},{"issue":"6","key":"4038_CR54","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1007\/s10620-021-07055-6","volume":"67","author":"E Guan","year":"2022","unstructured":"Guan E, Liu H, Xu N. Lidocaine suppresses gastric cancer development through Circ_ANO5\/miR-21-5p\/LIFR axis. Dig Dis Sci. 2022;67(6):2244\u201356.","journal-title":"Dig Dis Sci"},{"key":"4038_CR55","doi-asserted-by":"crossref","unstructured":"Tutino VM, Lu Y, Ishii D, Poppenberg KE, Rajabzadeh-Oghaz H, Siddiqui AH, et al. Aberrant whole blood gene expression in the lumen of human intracranial aneurysms. Diagnostics. 2021;11(8).","DOI":"10.3390\/diagnostics11081442"},{"issue":"1","key":"4038_CR56","first-page":"21","volume":"9","author":"Y Yamada","year":"2018","unstructured":"Yamada Y, Kato K, Oguri M, Horibe H, Fujimaki T, Yasukochi Y, et al. Identification of four genes as novel susceptibility loci for early-onset type 2 diabetes mellitus, metabolic syndrome, or hyperuricemia. Biomed Rep. 2018;9(1):21\u201336.","journal-title":"Biomed Rep"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04038-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04038-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04038-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:01:42Z","timestamp":1767031302000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04038-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4038"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04038-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"assertion":[{"value":"9 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of Xiangya Hospital, Central South University (Approval Number: 2025081132). All procedures performed in studies involving human participants were in accordance with the ethical standards of the Declaration of Helsinki. Informed consent for genetic analysis and data publication was obtained from both parents of two patients in the study prior to clinical data and sample collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents to submit and publish this case report were acquired from both parents of two patients in the study prior to submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2246"}}